Amgen Names New Board Member

Thousand Oaks-based biotech giant Amgen said Friday that it has named R. Sander Williams, M.D., to its board of directors. Williams is president of Gladstone Institutes, a nonprofit biomedical research enterprise, and is also a Professor of Medicine at the University of California, San Francisco. Amgen cited Williams' academic medicine background and experience in the industry as being of value to the company. AMgen has thirteen directors on its board.